Editor’s Introduction

An overview of the Summer 2012 issue on giving to medical research

By Christopher Levenick

From Philanthropy magazine, Summer 2012

The Accelerator

In business and philanthropy, Michael Milken has found ways to drive capital to promising upstarts and get them moving.

By Kari Barbic

From Philanthropy magazine, Summer 2012

In business and philanthropy, Michael Milken has found ways to drive capital to promising upstarts and get them moving. Not one to waste time, Milken has transformed the landscape of prostate cancer research through his strategic approach to funding, and he continues to be a leading figure in changing the way medical research is advanced.

The Fearless Philanthropist

How Jon Huntsman doubled down his efforts to treat and cure cancer.

By Christopher Levenick

From Philanthropy magazine, Summer 2012

Jon Huntsman Sr. has never shied away from outsized risks. Though his legendary courage was sorely tested when he learned he had prostate cancer, Huntsman responded in characteristic fashion. He doubled down and committed to building a top-flight research and treatment facility in his hometown of Salt Lake City. Editor-in-chief Christopher Levenick reports on Huntsman’s tireless efforts to treat and cure cancer.

Hope for the Addicted

Substance abuse is a plague on American society. Here are some of the donors looking to cure it.

By Tom Riley

From Philanthropy magazine, Summer 2012

Drugs are a cancer on American society. They debilitate individual lives—harming families, schools, workplaces, and communities. So why is funding for substance abuse recovery rarely talked about and highlighted in the philanthropic community? Contributing editor Tom Riley explores the stigmas behind drug addiction, as well as the different initiatives underway to curb this plague.

Mr. Unreasonable

Eli Broad on medical research; modern art; K–12 education; and his new book, The Art of Being Unreasonable

From Philanthropy magazine, Summer 2012

Eli Broad sits down with “Philanthropy” magazine to discuss his giving to medical research, modern art, and K–12 education.